FDA Approves Improvement to Unigene's Calcitonin Manufacturing Process.

Extract


FDA Approves Improvement to Unigene's Calcitonin Manufacturing Process.

FAIRFIELD, N.J. -- Unigene Laboratories, Inc. (OTCBB: UGNE) reported that the US Food and Drug Administration (FDA) approved a modification for a key enzyme, the first of two proposed improvements for its patented manufacturin...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company